Non-Medullary Thyroid Carcinoma
1 clinical trials · Condition
◉ Watch Non-Medullary Thyroid Carcinoma
| Record | Firm | Date |
|---|---|---|
| Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma (NCT05507775) | Radboud University Medical Center | 2022-12-06 |
Track Non-Medullary Thyroid Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.